Reduction in retinal ganglion cell loss with privosegtor in acute optic neuritis: post-hoc analysis of OCT scans (ARVO 2026) - May 8, 2026 - Abstract #4427; Pres time: May 6, 2026; 02:45 PM - 03:00 PM; Location: Mile High 1A; P2 | "However, measurement of larger areas of the macula still showed statistically robust findings due to reduced variability. Based on the observed neuroprotection and significant improvements in visual function demonstrated in the ACUITY trial, privosegtor potentially represents a novel first-in-class neuroprotective treatment for sparing neurons in optic nerve disease."
Retrospective data • Ocular Inflammation • Ophthalmology • Optic Neuritis
|
|
Martin Sebastian Zinkernagel1; Céline Louapre2; Sophie Bonnin3; Louise-Laure Mariani2,4; Mikael Cohen5; Caroline Froment Tilikete6; Mark J. Kupersmith7; Leonard A. Levin8; Sabri Markabi9; Caroline Papeix10,11; Valérie Touitou12; Rossella Medori13; Leila S. Eppenberger1; Marion R. Munk14,15; Pablo Villoslada16; Sebastian Wolf1
|